Jul 27, 2021
Leading endocrinologist, Dr Ted Wu, discusses the impact of insulin on the treatment of type 1 and type 2 diabetes. He delves into new treatment considerations and shares a personal insight into what drives him to help improve the health and wellbeing of people impacted by diabetes.
This podcast is not intended to replace the advice of a doctor, and listeners should direct any queries they have about diabetes, diabetes management and treatments to their doctor.
The views and opinions expressed in the podcast series should not be attributed to any organisation with which the speakers are employed or affiliated and are not necessarily the views of Sanofi Australia. Honoraria were provided to Dr Ted Wu.
Sanofi‐Aventis Australia Pty Ltd. ABN 31 008 558 807. Talavera Corporate Centre, Building D, 12‐24 Talavera Road, Macquarie Park, NSW 2113. MAT-AU-2101378. Date of preparation: July 2021.
REFERENCES